Literature DB >> 11857359

Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas.

Parviz Ghadirian1, Geoffrey Liu, Steven Gallinger, Beverly Schmocker, Anne-Josee Paradis, Geeta Lal, Jean-Sebastien Brunet, William D Foulkes, Steven A Narod.   

Abstract

In a hospital based case-control study of pancreatic cancer in Ontario and Quebec, a total of 174 incident pancreatic cancer cases and 136 healthy controls were compared for their family history of cancer. Information regarding the ages and sites of cancer was taken for 966 first-degree relatives of the cancer cases and for 903 first-degree relatives of the controls. A total of 150 cancer cases were reported among the relatives of the cases, compared to 122 cases among the relatives of the controls (relative risk 1.15; p = 0.23). Pancreatic cancer was the only site statistically in excess in the case relatives, compared to the control relatives (relative risk = 5.0; p = 0.01). The lifetime risk of pancreatic cancer was 4.7% for the first-degree relatives of the pancreatic cancer cases. The risk was 7.2% for relatives of cases diagnosed before age 60, and was 12.3% for relatives of patients with multiple primary cancers (all ages). These individuals comprise a high-risk group for pancreatic cancer and might benefit from enhanced surveillance or chemoprevention. Familial site-specific pancreatic cancer appears to be a distinct genetic entity, but contributes only modestly to the total burden of pancreatic cancer. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857359     DOI: 10.1002/ijc.10123

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Role of BRCA1 and BRCA2 mutations in pancreatic cancer.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

Review 2.  Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis.

Authors:  Jennifer Permuth-Wey; Kathleen M Egan
Journal:  Fam Cancer       Date:  2008-09-02       Impact factor: 2.375

Review 3.  Nutrition in Pancreatic Cancer: A Review.

Authors:  Simone Gärtner; Janine Krüger; Ali A Aghdassi; Antje Steveling; Peter Simon; Markus M Lerch; Julia Mayerle
Journal:  Gastrointest Tumors       Date:  2016-01-08

Review 4.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

5.  Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.

Authors:  Wigdan Al-Sukhni; Ayelet Borgida; Heidi Rothenmund; Spring Holter; Kara Semotiuk; Robert Grant; Stephanie Wilson; Malcolm Moore; Steven Narod; Kartik Jhaveri; Masoom A Haider; Steven Gallinger
Journal:  J Gastrointest Surg       Date:  2011-11-30       Impact factor: 3.452

6.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

7.  Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.

Authors:  Erica J Childs; Kari G Chaffee; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michele L Cote; Melissa L Bondy; Ralph H Hruban; Stephen J Chanock; Robert N Hoover; Charles S Fuchs; David N Rider; Laufey T Amundadottir; Rachael Stolzenberg-Solomon; Brian M Wolpin; Harvey A Risch; Michael G Goggins; Gloria M Petersen; Alison P Klein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-16       Impact factor: 4.254

8.  Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.

Authors:  Navdeep Chehl; Galina Chipitsyna; Qiaoke Gong; Charles J Yeo; Hwyda A Arafat
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

Review 9.  Familial Pancreatic Adenocarcinoma.

Authors:  Gloria M Petersen
Journal:  Hematol Oncol Clin North Am       Date:  2015-06-09       Impact factor: 3.722

Review 10.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.